Mutual of America Capital Management LLC Sells 650 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Mutual of America Capital Management LLC lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,175 shares of the medical device company’s stock after selling 650 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Cooper Companies were worth $1,955,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. T. Rowe Price Investment Management Inc. grew its position in Cooper Companies by 2.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company’s stock worth $705,928,000 after buying an additional 155,233 shares in the last quarter. JPMorgan Chase & Co. grew its position in Cooper Companies by 1.5% during the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock worth $460,066,000 after buying an additional 74,501 shares in the last quarter. Geode Capital Management LLC grew its position in Cooper Companies by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock worth $449,907,000 after buying an additional 109,907 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Cooper Companies by 517.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company’s stock valued at $324,466,000 after purchasing an additional 2,957,421 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Cooper Companies in the 4th quarter valued at $217,906,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the topic of a number of research analyst reports. Needham & Company LLC raised Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 target price on the stock in a report on Tuesday, June 17th. Mizuho dropped their price target on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday. Robert W. Baird dropped their price target on Cooper Companies from $107.00 to $97.00 and set an “outperform” rating for the company in a research note on Friday, May 30th. UBS Group upgraded Cooper Companies to a “buy” rating in a research note on Tuesday, June 17th. Finally, Wells Fargo & Company dropped their price target on Cooper Companies from $118.00 to $93.00 and set an “overweight” rating for the company in a research note on Friday, May 30th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.20.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $72.63 on Friday. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38. The stock’s 50 day moving average price is $74.03 and its 200-day moving average price is $81.98. The company has a market capitalization of $14.52 billion, a PE ratio of 35.26, a PEG ratio of 1.77 and a beta of 0.99. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. During the same quarter in the prior year, the business earned $0.85 earnings per share. Cooper Companies’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.